Success Metrics

Clinical Success Rate

84.0%

Based on 21 completed trials

Completion Rate

84%(21/25)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

4(15%)

Phase Distribution

Ph phase_1

48%

Ph phase_2

44%

Ph phase_3

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution27 total trials

Phase 1Safety & dosage

13(48.1%)

Phase 2Efficacy & side effects

12(44.4%)

Phase 3Large-scale testing

2(7.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

84.0%

21 of 25 finished

Non-Completion Rate

16.0%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(21)

Terminated(4)

Other(2)

Detailed Status

Completed21

Terminated4

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

84.0%

Most Advanced

Phase 3

Trials by Phase

Phase 113 (48.1%)

Phase 212 (44.4%)

Phase 32 (7.4%)

Trials by Status

completed2178%

terminated415%

unknown27%

Recent Activity

0 active trials

Showing 5 of 27

completedphase_1

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

NCT00004868

completedphase_2

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

NCT00005042

unknownphase_1

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT00005996

unknownphase_3

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

NCT00021281

completedphase_2

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

NCT00006002

View all 27 trials

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more

NCT00004868Phase 1

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

Completed

NCT00005042Phase 2

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Completed

NCT00005996Phase 1

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Unknown

NCT00021281Phase 3

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Unknown

NCT00006002Phase 2

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

Completed

NCT00006013Phase 2

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Completed

NCT00023725Phase 1

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Completed

NCT00026260Phase 2

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Completed

NCT00023738Phase 1

Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma

Completed

NCT00006001Phase 2

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Terminated

NCT00006014Phase 2

SU5416 in Treating Patients With Malignant Mesothelioma

Completed

NCT00005862Phase 2

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Completed

NCT00017316Phase 2

Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma

Completed

NCT00006000Phase 1

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Completed

NCT00006003Phase 2

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Terminated

NCT00005818Phase 1

SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer

Completed

NCT00005942Phase 1

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Completed

NCT00009919Phase 2

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

Terminated

NCT00004252Phase 3

Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Completed

NCT00003720Phase 1

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 27